Showing 1 - 6 results of 6 for search 'Cissy M Kityo', query time: 0.03s Refine Results
  1. 1
    Persistence of traditional and emergence of new structural drivers and factors for the HIV epidemic in rural Uganda; A qualitative study.

    Persistence of traditional and emergence of new structural drivers and factors for the HIV epidemic in rural Uganda; A qualitative study. by Francis Bajunirwe, Denis Akakimpa, Flora P Tumwebaze, George Abongomera, Peter N Mugyenyi, Cissy M Kityo

    Published 2019-01-01
    Get full text
    Article
  2. 2
    Using Exclusion-Based Sample Preparation (ESP) to Reduce Viral Load Assay Cost.

    Using Exclusion-Based Sample Preparation (ESP) to Reduce Viral Load Assay Cost. by Scott M Berry, Hannah M Pezzi, Eram D Williams, Jennifer M Loeb, David J Guckenberger, Alex J Lavanway, Alice A Puchalski, Cissy M Kityo, Peter N Mugyenyi, Franklin M Graziano, David J Beebe

    Published 2015-01-01
    Get full text
    Article
  3. 3
    Reduced and highly diverse peripheral HIV-1 reservoir in virally suppressed patients infected with non-B HIV-1 strains in Uganda

    Reduced and highly diverse peripheral HIV-1 reservoir in virally suppressed patients infected with non-B HIV-1 strains in Uganda by Samira Joussef-Piña, Immaculate Nankya, Sophie Nalukwago, Joy Baseke, Sandra Rwambuya, Dane Winner, Fred Kyeyune, Keith Chervenak, Bonnie Thiel, Robert Asaad, Curtis Dobrowolski, Benjamin Luttge, Blair Lawley, Cissy M. Kityo, W. Henry Boom, Jonathan Karn, Miguel E. Quiñones-Mateu

    Published 2022-01-01
    Get full text
    Article
  4. 4
    Previous antiretroviral drug use compromises standard first-line HIV therapy and is mediated through drug-resistance

    Previous antiretroviral drug use compromises standard first-line HIV therapy and is mediated through drug-resistance by Seth C. Inzaule, Cissy M. Kityo, Margaret Siwale, Alani Sulaimon Akanmu, Maureen Wellington, Marleen de Jager, Prudence Ive, Kishor Mandaliya, Wendy Stevens, T. Sonia Boender, Pascale Ondoa, Kim C. E. Sigaloff, Denise Naniche, Tobias F. Rinke de Wit, Raph L. Hamers

    Published 2018-10-01
    Get full text
    Article
  5. 5
    Changes over time in creatinine clearance and comparison of emergent adverse events for HIV-positive adults receiving standard doses (300 mg/day) of lamivudine-containing antiretroviral therapy with baseline creatinine clearance of 30-49 vs ≥50 mL/min.

    Changes over time in creatinine clearance and comparison of emergent adverse events for HIV-positive adults receiving standard doses (300 mg/day) of lamivudine-containing antiretro... by Lisa L Ross, A Sarah Walker, Yu Lou, Allan R Tenorio, Diana M Gibb, Julia Double, Charles Gilks, Cynthia C McCoig, Paula Munderi, Godfrey Musoro, Cissy M Kityo, Heiner Grosskurth, James Hakim, Peter N Mugyenyi, Amy Cutrell, Teodora Perger, Mark S Shaefer

    Published 2019-01-01
    Get full text
    Article
  6. 6
    ODYSSEY clinical trial design: a randomised global study to evaluate the efficacy and safety of dolutegravir-based antiretroviral therapy in HIV-positive children, with nested pharmacokinetic sub-studies to evaluate pragmatic WHO-weight-band based dolutegravir dosing

    ODYSSEY clinical trial design: a randomised global study to evaluate the efficacy and safety of dolutegravir-based antiretroviral therapy in HIV-positive children, with nested phar... by Cecilia L. Moore, Anna Turkova, Hilda Mujuru, Adeodata Kekitiinwa, Abbas Lugemwa, Cissy M. Kityo, Linda N. Barlow-Mosha, Tim R. Cressey, Avy Violari, Ebrahim Variava, Mark F. Cotton, Moherndran Archary, Alexandra Compagnucci, Thanyawee Puthanakit, Osee Behuhuma, Yacine Saϊdi, James Hakim, Pauline Amuge, Lorna Atwine, Victor Musiime, David M. Burger, Clare Shakeshaft, Carlo Giaquinto, Pablo Rojo, Diana M. Gibb, Deborah Ford, the ODYSSEY Trial Team

    Published 2021-01-01
    Get full text
    Article

Search Tools: